[A Meta-analysis of high-dose epinephrine in children with cardiopulmonary arrest]

Jie Gu1, Yu Jin, Ke-hu Yang

  • 1Department of Pediatrics, The First Hospital, Lanzhou University, Lanzhou 730000, China.

Insights

Higher doses of epinephrine (adrenaline) in pediatric cardiopulmonary arrest do not improve survival rates. This meta-analysis found no significant difference in spontaneous circulation recovery or survival at 24 hours or hospital discharge.

Area of Science:

  • Pediatric Critical Care Medicine
  • Emergency Medicine
  • Pharmacology

Context:

  • Pediatric cardiopulmonary arrest (CPA) is a critical condition requiring immediate intervention.
  • Epinephrine (adrenaline) is a standard treatment for CPA, but optimal dosing remains debated.
  • Evidence regarding the effectiveness of different epinephrine doses in pediatric CPA is limited.

Purpose:

  • To systematically review and meta-analyze existing evidence on the effectiveness of various epinephrine doses in pediatric CPA.
  • To compare the efficacy of high-dose versus standard-dose epinephrine in improving outcomes for children experiencing cardiac arrest.

Summary:

  • This meta-analysis included four trials with 360 pediatric CPA cases.
  • Results indicated no statistically significant difference in the recovery of spontaneous circulation between different epinephrine doses.
  • Analysis of survival rates at 24 hours and hospital discharge also showed no significant improvements with higher epinephrine doses, with some heterogeneity noted in the studies.

Impact:

  • The findings suggest that higher doses of epinephrine may not enhance recovery or survival rates in pediatric CPA.
  • Further research is needed to fully evaluate potential adverse effects and neurological outcomes associated with different epinephrine dosages.
  • This evidence can inform clinical guidelines and treatment protocols for pediatric cardiac arrest management.
Abstract

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...